A new pyrimidine catabolic pathway (Rut pathway) was recently discovered in Escherichia coli K121, 2. In this pathway, uracil (1) (or thymine) is converted to 3-hydroxypropionate (2) (or 2-methyl-3-hydroxypropionate), two equivalents of ammonia and one equivalent of carbon dioxide1. The b1012 operon, containing seven genes (RutA-G) is required for this conversion. Here we demonstrate that the flavoenzyme RutA, along with the flavin reductase RutF, catalyzes the initial uracil ring opening by an unprecedented “oxidative” hydrolysis reaction to give 3-ureidoacrylate (3, Scheme 1).
Scheme 1.

(a) The new pyrimidine catabolic pathway in E. coli K12. (b) The reaction catalyzed by RutA.
RutA and RutF were overexpressed in E. coli BL-21 and purified by Ni-affinity chromatography. RutA overexpressed well and was purified to homogeneity. RutF also overexpressed well but most of the protein was insoluble and this protein was only partially purified. When uracil (1) was incubated at 25 °C in the presence of RutA, RutF, NADH and FMN, the formation of 3-ureidoacrylate (3) was detected by HPLC analysis Figure 1(A). Attempts to isolate and characterize the product by 1H-NMR and ESI-MS were unsuccessful because it was unstable to acid and degraded during lyophilization. To characterize the product without isolation, a reaction mixture containing 13C15N labeled uracil (1), RutA, RutF, NADH and FMN in phosphate buffer at pH 8.0 was incubated at room temperature overnight and analyzed by 13C NMR. The spectrum of the product showed no coupling between N3 and C4 demonstrating that RutA catalyzed the cleavage of the N3-C4 bond as the first step of the Rut pathway (Figure 1(B)). An identical reaction product was obtained by substituting RutF with homogeneous Fre, a flavin reductase.3
Figure 1.
A: HPLC chromatogram of a time course for the RutA/RutF catalyzed ring opening of uracil. B: Partial 13C NMR spectra of the C4 resonance of 13C15N uracil showing the C4-N3 coupling. This coupling is absent in the reaction product. C: 13C NMR showing isotopic shift at C4 of the product when the reaction was run in the presence of 18O2 (right). No isotopic shift was observed when the reaction was run in H2O18 (left).
Three plausible structures for the N3-C4 bond-cleaved product (3, 5 & 6) are shown in Scheme 2. Addition of the flavin hydroperoxide, generated by reaction of molecular oxygen with reduced flavin, to C4 of uracil would give 4, which could then undergo a Baeyer Villiger like rearrangement to give 5 or 7. Hydrolysis of 5 would give 6 and reduction of 7 would give 3. To differentiate between 3/5 and 6, the RutAF reaction was run in 50% H2O18 buffer using 13C15N labeled uracil (1). NMR analysis showed no isotopic shift at C4 for the product (Figure 1(C)). This rules out 6 as the enzymatic product. In further support of this, when the reaction was run using 18O2/16O2, a clear isotopic shift at C4 of the product was observed (Figure 1(C)). To differentiate between compounds 3 and 5, the reaction product was hydrolyzed with 10% trifluoroacetic acid: 5 should generate hydroxyurea and 3 should yield urea. In the event, 13C-NMR analysis of the reaction mixture showed a triplet (coupling to N1 and N3) at 162.7 ppm consistent with the formation of urea. Thus, the RutAF product is likely to be the 3-ureidoacrylate (3). This was confirmed by NMR and chromatographic identity with a synthesized sample of 3-ureidoacrylate.
Scheme 2.

Three plausible structures for the RutA product.
A mechanistic hypothesis for the formation of (Z)-3-ureidoacrylic acid (3) is outlined in Scheme 3. In this proposal, RutF (or Fre) catalyzes the formation of dihydroflavin (11) which then reacts with molecular oxygen to form the flavin hydroperoxide (12)4. This then adds to the C4 carbonyl of uracil (1) to form (13), which undergoes ring opening to (14). Elimination of the (Z)-3-ureidoacrylic peracid (15) followed by reduction of the acylhydroperoxide completes the reaction.
Scheme 3.

Mechanistic proposal for the formation of (Z)-3-ureidoacrylic acid (3).
We have not detected the formation of 15 in our reaction mixtures either by NMR or by HPLC using a reference sample of 15 (see below). This suggests that it is rapidly reduced to 3 under the reaction conditions because the oxygen labeling experiment (Figure 1(C)) eliminates the possibility of acyl hydroperoxide hydrolysis. Two mechanisms for this reduction were considered: RutA-catalyzed reduction or reduction by excess NADH or DTT in the reaction buffer.
Flavoenzyme catalyzed hydroperoxide reduction is a well-characterized process that occurs by oxidation of an active site cysteine followed by flavin mediated reduction of the resulting sulfenic acid 6. To address the possibility of enzymatic reduction of 15, the X-ray crystal structure of RutA was solved at 1.8 Å. The active site is shown in Figure 2(A). While we have not yet been able to obtain a structure of the enzyme substrate complex, we can identify a substrate-binding site above the Si-face of the isoalloxazine ring. Since there are no cysteine residues located in this region of the protein, we conclude that reduction of 15 is not enzyme catalyzed.
Figure 2.
(a) Stereo view active site of RutA. (b) 1H NMR (300 MHz, D2O) of decomposed (Z)-3-ureidoacrylic peracid (15) at 25° C showing a mixture of 1, 3 and 15. (c) 1H NMR (300 MHz, D2O) of the (Z)-3-ureidoacrylic peracid (15) in presence and absence of NADH at 25 °C.
To evaluate the chemical stability of 15 in the reaction buffer, an authentic sample of 15 was synthesized by the reaction of Na2O2 with the p-nitrophenolate (PNP) ester of (Z)-3-ureidoacrylate (3). This compound decomposes over time to form primarily (Z)-3-ureidoacrylic acid (3) and uracil (1) (Figure 2(C)). The half life of 15 is 3 hours at pH 10.0 at 25 °C and much less at lower pH. In the presence of 1.5 equivalents of NADH, a freshly prepared sample of (Z)-3-ureidoacrylic peracid (15) was completely converted to (Z)-3-ureidoacrylic acid (3) within five minutes (Figure 2 (D)). A similar rapid reduction was observed using DTT. These results suggested that the (Z)-3-ureidoacrylic peracid (15) formed during the enzymatic reaction is reduced to the (Z)-3-ureidoacrylic acid (3) non-enzymatically under our reaction conditions. However, the possibility remains that one of the other enzymes in the Rut pathway catalyzes this reduction.
We have demonstrated that the first step in the RUT pyrimidine catabolic pathway involves the ring opening of uracil at the C4 carbonyl. This reaction, while formally a hydrolysis reaction, proceeds by an oxidative mechanism initiated by the addition of a flavin hydroperoxide to the C4 carbonyl. While peroxide catalyzed amide hydrolysis has chemical precedence5, we are not aware of a prior example of analogous chemistry catalyzed by flavin hydroperoxides. This study further illustrates the extraordinary catalytic versatility of the flavin cofactor.
Supplementary Material
ACKNOWLEDGMENTS
This research was supported by NIH grants R01AI066244 and GM073220. We thank Ivan Keresztes for assistance with the NMR analysis, Andrei Osterman, for providing the Rut overexpression strains, Sheng Zhang for LCEMS analysis and Professors David Wemmer and Sidney Kustu for sharing with us their unpublished results reaching similar conclusions on the function of RutA.
Footnotes
SUPPORTING INFORMATION Detailed experimental procedures for the synthesis of 3 and 15, protein purification, enzymatic assays and NMR and LC-EMS analysis. This material is available free of charge via the Internet at http://pubs.acs.org.
REFERENCES
- 1.Loh KD, Gyaneshwar P, Papadimitriou E. Markenscoff, Fong R, Kim KS, Parales R, Zhou Z, Inwood W, Kustu S. Proc Natl Acad Sci U S A. 2006;103(13):5114–9. doi: 10.1073/pnas.0600521103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Osterman A. Proc Natl Acad Sci U S A. 2006;103(15):5637–8. doi: 10.1073/pnas.0601119103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Xun L, Sandvik ER. Appl Environ Microbiol. 2000;66(2):481–6. doi: 10.1128/aem.66.2.481-486.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Massey V. Journal of Biological Chemistry. 1994;269:22459–22462. [PubMed] [Google Scholar]
- 5.Vaughn HLR,MD. Journal of Organic Chemistry. 1975;40(8):1187–1189. [Google Scholar]
- 6.Hall AK,PA, Poole Leslie B. FEBS Journal. 2009;276(9):2469–2477. doi: 10.1111/j.1742-4658.2009.06985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


